PT Jayamas Medica Industri Tbk (IDX:OMED)

IDX:OMED Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,932,020	1,885,822	1,736,990	1,739,054	2,226,573	1,994,540
Revenue Growth (YoY)	7.02%	8.57%	-0.12%	-21.89%	11.63%	62.41%
Cost of Revenue	1,288,504	1,261,846	1,184,990	1,176,045	1,322,544	957,599
Gross Profit	643,516	623,976	552,000	563,010	904,030	1,036,940
Selling, General & Admin	293,432	275,502	250,002	198,309	168,243	186,715
Other Operating Expenses	-2,201	3,016	1,842	-7,542	2,951	736.38
Operating Expenses	291,283	278,518	251,843	190,767	171,194	187,451
Operating Income	352,233	345,458	300,156	372,243	732,836	849,489
Interest Expense	-17,672	-19,768	-19,581	-20,805	-21,840	-9,008
Interest & Investment Income	61,546	57,008	43,520	14,371	16,909	14,945
Currency Exchange Gain (Loss)	9,584	11,911	1,654	6,704	1,445	5,821
Other Non Operating Income (Expenses)	-473.75	-460.86	-341.03	-403.98	-328.64	-149.77
EBT Excluding Unusual Items	405,217	394,148	325,409	372,109	729,020	861,098
Gain (Loss) on Sale of Assets	-238.86	-121.48	35.59	0.04	179.92	583.7
Pretax Income	404,978	394,026	325,444	372,109	729,200	861,681
Income Tax Expense	71,585	70,074	64,462	81,602	158,821	168,812
Earnings From Continuing Operations	333,393	323,952	260,982	290,507	570,379	692,869
Minority Interest in Earnings	-1,937	-2,279	-1,622	-4,725	-7,687	-7,359
Net Income	331,456	321,673	259,360	285,782	562,692	685,510
Net Income to Common	331,456	321,673	259,360	285,782	562,692	685,510
Net Income Growth	13.24%	24.03%	-9.25%	-49.21%	-17.92%	203.04%
Shares Outstanding (Basic)	27,058	27,059	27,059	27,059	27,059	27,455
Shares Outstanding (Diluted)	27,058	27,059	27,059	27,059	27,059	27,455
Shares Change (YoY)	-0.00%	-	-	-	-1.44%	-46.28%
EPS (Basic)	12.25	11.89	9.59	10.56	20.80	24.97
EPS (Diluted)	12.25	11.89	9.59	10.56	20.80	24.97
EPS Growth	13.25%	24.03%	-9.25%	-49.21%	-16.71%	464.16%
Free Cash Flow	267,805	249,245	-22,031	17,549	422,386	228,771
Free Cash Flow Per Share	9.90	9.21	-0.81	0.65	15.61	8.33
Dividend Per Share	3.570	3.570	6.050	-	10.870	17.000
Dividend Growth	23.96%	-40.99%	-	-	-36.06%	-
Gross Margin	33.31%	33.09%	31.78%	32.37%	40.60%	51.99%
Operating Margin	18.23%	18.32%	17.28%	21.40%	32.91%	42.59%
Profit Margin	17.16%	17.06%	14.93%	16.43%	25.27%	34.37%
Free Cash Flow Margin	13.86%	13.22%	-1.27%	1.01%	18.97%	11.47%
EBITDA	398,750	388,670	334,660	392,559	752,142	864,958
EBITDA Margin	20.64%	20.61%	19.27%	22.57%	33.78%	43.37%
D&A For EBITDA	46,517	43,213	34,504	20,317	19,307	15,469
EBIT	352,233	345,458	300,156	372,243	732,836	849,489
EBIT Margin	18.23%	18.32%	17.28%	21.40%	32.91%	42.59%
Effective Tax Rate	17.68%	17.78%	19.81%	21.93%	21.78%	19.59%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.